A phase I trial of combination fludarabine monophosphate and chlorambucil in chronic lymphocytic leukemia: a Southwest Oncology Group study.
Laurence Elias(Pharmacyclics (United States)), Frederick R. Appelbaum(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Michael R. Grever(The Ohio State University Wexner Medical Center), John E. Godwin(Providence Portland Medical Center), David R. Head(University of Southern California), James K. Weick(Cleveland Clinic), Robert Chapman, Earl N. Metz(The Ohio State University), Donna Stock-Novack(SWOG Cancer Research Network)
PubMed
March 1, 1993
Cited by 63
Related Papers
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
|Nature|2000|10k
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
|Blood|2022|3.1k
Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a <i>FLT3</i> Mutation
|New England Journal of Medicine|2017|2.2k